0001950047-23-005922.txt : 20231212 0001950047-23-005922.hdr.sgml : 20231212 20231212163722 ACCESSION NUMBER: 0001950047-23-005922 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231212 DATE AS OF CHANGE: 20231212 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 231481687 BUSINESS ADDRESS: STREET 1: 1000 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1000 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: CAUSEY CHRISTOPHER CENTRAL INDEX KEY: 0001237334 FILING VALUES: FORM TYPE: 144 144 1 primary_doc.xml 144 0001237334 XXXXXXXX LIVE 0001082554 UNITED THERAPEUTICS CORPORATION 000-26301 1000 Spring Street SILVER SPRING MD 20910 (301) 608-9292 CHRISTOPHER CAUSEY Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Floor New York NY 10004

3000 749033.70 46993601 12/12/2023 NASDAQ Common 12/12/2023 Stock Option Exercise Issuer N 3000 12/12/2023 Cash Y 12/12/2023 /s/ Christopher Causey